UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
Report on Form 6-K dated February 13, 2018
 
Commission File Number: 001-15092
 


TURKCELL ILETISIM HIZMETLERI A.S.
(Translation of registrant’s name in English)

Aydınevler Mahallesi İnönü Caddesi No:20
Küçükyalı Ofispark
34854 Maltepe
Istanbul, Turkey

(Address of Principal Executive Offices)



 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F           Form 40-F
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
 
Yes           No 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
 
Yes           No 
 
Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes           No 
 
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- __________
 
Enclosure: A press release dated February 13, 2018, regarding the capital increase in Lifecell Ventures.



 

 
 
Istanbul, February 13, 2018
 
Announcement Regarding the Capital Increase in Lifecell Ventures


The capital of our 100% owned subsidiary Lifecell Ventures Coöperatief U.A. (“Lifecell Ventures”) is increased by USD 30,000,000 (EUR 24,463,834) to EUR 1,680,675,660. Our Company’s pre-emption rights with respect to the capital increase are fully paid.
 

For more information:
 
Turkcell Investor Relations
 
investor.relations@turkcell.com.tr
 
Tel: + 90 212 313 1888

 
 
 
 

 
SIGNATURES

 
Pursuant to the requirements of the Securities Exchange Act of 1934, Turkcell Iletisim Hizmetleri A.S. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
TURKCELL ILETISIM HIZMETLERI A.S.
 
     
     
Date:  February 13, 2018
By:
 /s/ Zeynel Korhan Bilek
 
 
Name:
Zeynel Korhan Bilek
 
 
Title:
Investor Relations and Mergers & Acquisition Director
 
       

 
 
TURKCELL ILETISIM HIZMETLERI A.S.
 
     
     
Date:  February 13, 2018
By:
 /s/Bulent Aksu
 
 
Name:
Bulent Aksu
 
 
Title:
Finance Executive Vice President